Vyvgart Hytrulo

Active Ingredient(s): Efgartigimod Alfa + Hyaluronidase-qvfc
FDA Approved: * June 20, 2023
Pharm Company: * ARGENX BV
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vyvgart Hytrulo Subcutaneous Injection, Solution
NDC: 73475-3102
Labeler:
Argenx Us

Related Brands

Drugs with the same active ingredients